Topic: Biotechnology

Recent $31 million damages award has dealt a further blow to the company's faltering share value

The revocation has major implications for the covid-19 vaccine patent wars

Green light for first ever Cas9 therapy ushers in next phase of licensing and litigation efforts.

Lawsuit is latest in a torrent of new BPCIA lawsuits to emerge over the past year

16 November 2023

What you need to know about one of 2023's most important patent wars

14 November 2023

The commission recently vowed to take action on alleged anticompetitive IP tactics

13 November 2023

Munich Regional Court has become the first to wade in on disputes over drugs exports under Europe’s SPC exemption

06 November 2023

Chief Legal Officer Yoori Kim argues that current patent uncertainty should fuel rather than thwart licensing deals

01 November 2023

Latest agreement continues long-running pattern of dispute resolution tactics in biologics space

26 October 2023

Appellate court overturns Munich local division ruling in Amgen/Sanofi dispute

19 October 2023

Narrow safe harbor immunity and platform technology patents are creating both pitfalls and opportunities

08 September 2023

NanoString Technologies is facing an injunction at the UPC, which has scheduled several further PI hearings in Munich and Vienna

06 September 2023

IAM speaks exclusively to Christopher Arnot about the crowded CRISPR IP landscape

25 August 2023

Unlock unlimited access to all IAM content